Varenicline Treatment for Cannabis Use Disorder
Completed · Phase 2 · Has a placebo group
Conditions studied: Substance Use Disorder
In brief
Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.
Key facts
- Study ID
- NCT02892110
- Run by
- Medical University of South Carolina
- People needed
- 72
- Starts
- 2017-02-13
- Expected to finish
- 2018-11-27
- Last updated by the study team
- 2019-12-03
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.